CPHI South East Asia 2024 has been successfully organized in Bangkok,
Thailand and will be hosting in Malaysia next year.
CPHI South East Asia 2024, the region’s leading pharmaceutical technology and innovation trade show, has been organized successfully in Bangkok, Thailand this year, the event was helping to promote pharmaceutical security, increase accessibility to high-quality pharmaceutical products, and elevate the Thai pharmaceutical industry as the healthcare and medical hub of ASEAN, and will be hosting by Malaysia for next year.
Upon the MOU signing ceremony between MATRADE and Informa Markets, the international organizer of the trade show, YB Dato’ Sri Reezal Merican Naina Merican, Malaysia External Trade Development Corporation (MATRADE)’s Chairman, has officially announced to be the host of CPHI South East Asia 2025.
YB Dato’ Sri Reezal Merican Naina Merican added, Malaysian government aims to become a Centre of Excellence in South East Asia by 2030, and hosting this event in Malaysia will support the medical and devices industry development through networking, knowledge sharing, and the exhibition of interesting innovations and technologies.
Malaysia views the healthcare industry as a key economic driver. In 2023, Malaysia’s total trade in the healthcare industry was valued at USD 11.1 billion. Healthcare product exports amounted to USD 6.81 billion, while total imports totalled USD 4.29 billion. The momentum will continue in 2024, with the Malaysian government expecting the medical and devices sector to contribute USD 4.91 billion to its economy. The pharmaceutical segment has already added over USD 1.26 billion to the country’s GDP. At present, Malaysia’s medical devices industry employs over 13,000 individuals, and the pharmaceutical industry provides jobs for almost 30,000 people.
Next year, Malaysia’s MATRADE and Informa Markets will jointly organise CPHI South East Asia, the largest pharma and medical devices trade show and conference in South East Asia. Every year, it brings together over 750 exhibitors and 10,000 trade visitors from different sectors in the healthcare industry.
Ms. Rungphech Chitanuwat, Regional Portfolio Director – ASEAN, Informa Markets and Country General Manager – Philippines, expressed the company’s readiness for CPHI South East Asia 2024, Asia’s leading pharmaceutical technology and innovation exhibition. The event aims to create new opportunities and improve the Thai pharmaceutical industry to ensure pharmaceutical security, driving Thailand towards becoming ASEAN’s largest and fastest-growing medical hub.
“The company expects the event will attract 18,000 visitors and provide business matching opportunities for around 2,000 businesses during the three-day event,” she said. Highlights of the event include over 400 brands from 50 countries, such as the Philippines, Myanmar, Indonesia, Singapore, Vietnam, and Cambodia. The event will also showcase healthcare and medical innovations from 10 related industry profiles, including reactants, medicine, herbal medicine, machinery, packaging, testing equipment, OEM, logistics, warehouses, chemicals, and natural extracts.
For the overall trade show market, Ms. Rungphech Chitanuwat also added that, as the International trade show organizer, Thailand is still potential to grow as an international conference center, as well as MICE Hub in ASEAN, especially in Bangkok as an ideal location with prompt infrastructure, facilities and lifestyle attractions.
